Aegerion Pharmaceuticals, Inc. to Announce Third Quarter 2012 Financial Results on Wednesday, November 7

Published: Oct 26, 2012

CAMBRIDGE, Mass., Oct. 26, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EST on Wednesday, November 7, 2012, to provide a business update and discuss its third quarter 2012 financial and operational results.

Back to news